CN85108260A - 巴卡西林盐酸化物的稳定方法 - Google Patents

巴卡西林盐酸化物的稳定方法 Download PDF

Info

Publication number
CN85108260A
CN85108260A CN198585108260A CN85108260A CN85108260A CN 85108260 A CN85108260 A CN 85108260A CN 198585108260 A CN198585108260 A CN 198585108260A CN 85108260 A CN85108260 A CN 85108260A CN 85108260 A CN85108260 A CN 85108260A
Authority
CN
China
Prior art keywords
bacampicillin hydrochloride
bacampicillin
hydrochloride
water vapour
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN198585108260A
Other languages
English (en)
Chinese (zh)
Inventor
乌尔夫·安德斯·克杰尔伯格
佩尔·古斯塔夫·哈坎·尼克维斯特
简·厄本·斯坦赫德
拉尔斯·伯蒂尔·斯坦马克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of CN85108260A publication Critical patent/CN85108260A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04—Preparation
    • C07D499/14—Preparation of salts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN198585108260A 1984-11-09 1985-11-09 巴卡西林盐酸化物的稳定方法 Pending CN85108260A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8405611A SE8405611D0 (sv) 1984-11-09 1984-11-09 Process for stabilization of bacampicillin hydrochloride
SE8405611-8 1984-11-09

Publications (1)

Publication Number Publication Date
CN85108260A true CN85108260A (zh) 1986-04-10

Family

ID=20357678

Family Applications (1)

Application Number Title Priority Date Filing Date
CN198585108260A Pending CN85108260A (zh) 1984-11-09 1985-11-09 巴卡西林盐酸化物的稳定方法

Country Status (23)

Country Link
US (1) US4626532A (enExample)
EP (1) EP0187626A1 (enExample)
JP (1) JPS61115031A (enExample)
KR (1) KR860004065A (enExample)
CN (1) CN85108260A (enExample)
AU (1) AU581694B2 (enExample)
CS (1) CS251799B2 (enExample)
DD (1) DD239206A5 (enExample)
DK (1) DK509085A (enExample)
EG (1) EG17292A (enExample)
ES (1) ES8704176A1 (enExample)
FI (1) FI854340L (enExample)
GB (1) GB2167067B (enExample)
GR (1) GR852706B (enExample)
HU (1) HUT40135A (enExample)
IL (1) IL76727A (enExample)
NZ (1) NZ214096A (enExample)
PH (1) PH21760A (enExample)
PL (1) PL256116A1 (enExample)
PT (1) PT81455B (enExample)
SE (1) SE8405611D0 (enExample)
YU (1) YU167085A (enExample)
ZA (1) ZA858043B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1041217A1 (zh) 1998-08-04 2002-07-05 藤泽药品工业株式会社 β-内酰胺抗生素的稳定化制剂
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US8986781B2 (en) * 2005-10-27 2015-03-24 Corning Incorporated Immobilized multi-layer artificial membrane for permeability measurements (PAMPA)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293590A (en) * 1969-11-11 1972-10-18 Leo Pharm Prod Ltd New penicillanic acid derivatives
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture

Also Published As

Publication number Publication date
PT81455A (en) 1985-12-01
YU167085A (en) 1988-12-31
PL256116A1 (en) 1988-05-12
JPS61115031A (ja) 1986-06-02
AU581694B2 (en) 1989-03-02
HUT40135A (en) 1986-11-28
NZ214096A (en) 1988-09-29
PH21760A (en) 1988-02-18
FI854340A7 (fi) 1986-05-10
FI854340A0 (fi) 1985-11-05
GB2167067A (en) 1986-05-21
SE8405611D0 (sv) 1984-11-09
EG17292A (en) 1990-08-30
IL76727A0 (en) 1986-02-28
KR860004065A (ko) 1986-06-16
US4626532A (en) 1986-12-02
IL76727A (en) 1989-09-10
FI854340L (fi) 1986-05-10
GB8527612D0 (en) 1985-12-11
ES548698A0 (es) 1987-03-16
CS251799B2 (en) 1987-08-13
DD239206A5 (de) 1986-09-17
AU4938285A (en) 1986-05-15
EP0187626A1 (en) 1986-07-16
GB2167067B (en) 1988-06-22
PT81455B (en) 1987-09-17
ZA858043B (en) 1987-04-29
ES8704176A1 (es) 1987-03-16
DK509085D0 (da) 1985-11-05
GR852706B (enExample) 1986-03-10
DK509085A (da) 1986-05-10

Similar Documents

Publication Publication Date Title
CN1261163C (zh) 大环内酯的稳定化
EP0317878B1 (de) Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen
WO1996004908A1 (en) Pharmaceutical formulation containing amoxycillin and potassium clavulanate
JPS62258320A (ja) 内服用新規医薬製剤
CN1462186A (zh) 稳定的氨基酸固体剂型和它们的制备方法
EP0622083B1 (en) Taste masked solid preparation and its production
US6388112B1 (en) Process for purification of solvents useful in the preparation of pharmaceutical compositions
SI20747A (sl) Nekristalen cefuroksim aksetilni trden dispergator, postopek za njegovo pripravo in njegovi preparati za oralno uporabo
AU2004261143B2 (en) A doxycycline metal complex in a solid dosage form
CN85108260A (zh) 巴卡西林盐酸化物的稳定方法
CN1083267C (zh) 山楂的提取产物、药用组合物及其用途
DE4124409B4 (de) Pharmazeutische Zubereitungen
DE60002454T2 (de) Granulat mit hohem gehalt an l-carnitine oder einem alkanoyl l-carnitine, insbesondere für die herstellung von direktverpressten tabletten
CN85101697A (zh) 二氢吡啶化合制剂及其制备方法
EP2800477B1 (en) Method for purifying bee venom on mass scale
AU712904B2 (en) Improved process for preparing potassium clavulanate
JPH0249720A (ja) 難溶性薬剤組成物
US5622723A (en) Procedure for encapsulating chlorpheniramine
WO2021044350A1 (en) Solid forms of encequidar mesylate and processes thereof
KR950015059B1 (ko) 오메프라졸의 신규 경구용 약제
DE1617302C (de) Verfahren zur Herstellung eines einen Wismut Polygalacturon Komplex enthaltenden Gemische
JP2000290188A (ja) キサンチンオキシダーゼ阻害剤
KR840001002B1 (ko) 코밤아미드나 메코발아민을 함유하는 고체제제의 제조방법
WO2023147443A2 (en) Novel compositions
RU97116007A (ru) Фармацевтическая композиция с регулируемым высвобождением для перорального введения, содержащая в качестве активного ингредиента нифедипин, способ ее получения

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication